| Original language | English |
|---|---|
| Article number | e2217150 |
| Journal | JAMA network open |
| Volume | 5 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Jun 6 2022 |
Funding
Conflict of Interest Disclosures: Dr Villanti reported receiving grants from the National Institutes of Health during the conduct of the study. Dr Rose reported receiving grants from the National Cancer Institute and Truth Initiative during the conduct of the study and personal fees from the US Food and Drug Administration via Versar (honoraria for review panel) outside the submitted work. No other disclosures were reported. Funding/Support: The authors receive funding from the National Institutes of Health and Food and Drug Administration under award numbers R21DA051943 (to Dr Villanti), R01DA051001 (to Dr Villanti), R01CA228906 (to Dr Sterling), and R01CA251478 (to Dr Rose).
| Funders | Funder number |
|---|---|
| Truth Initiative | |
| U.S. Food and Drug Administration | |
| National Institute on Drug Abuse | R21DA051943, R01DA051001 |
| National Institutes of Health and Food and Drug Administration | R21DA051943, R01CA228906, R01DA051001, R01CA251478 |
| National Childhood Cancer Registry – National Cancer Institute | R01CA228906, R01CA251478 |
ASJC Scopus subject areas
- General Medicine